GUFICBIO.BO

Gufic Biosciences Limited is a pharmaceutical enterprise engaged in the global development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), generic medications, and associated services. The company's extensive international presence spans India, Africa, Asia, Europe, Australia, North America, South America, and other global regions. Its production capabilities encompass APIs and bulk drug substances, including compounds for antifungals, anesthetics, immunosuppressants, and key antifungal intermediates. Additionally, Gufic Biosciences specializes in creating lyophilized injectable products across therapeutic areas such as antibiotics, antifungals, cardiology, infertility, antivirals, and proton-pump inhibitors. The firm's comprehensive portfolio also features pharmaceutical brands like Spark, Criti Care, Criticare Life, and Ferticare, alongside offerings in herbal medicine, aesthetic dermatology (aesthaderm), gufic stridden, and personal care products. These varied products are supplied to major hospital networks and a broad spectrum of medical facilities. Established in 1970, Gufic Biosciences Limited has its headquarters in Mumbai, India.